BR112014026292A2 - comprimido oralmente desintegrável, e, processo para a produção de um comprimido oralmente desintegrável - Google Patents

comprimido oralmente desintegrável, e, processo para a produção de um comprimido oralmente desintegrável

Info

Publication number
BR112014026292A2
BR112014026292A2 BR112014026292A BR112014026292A BR112014026292A2 BR 112014026292 A2 BR112014026292 A2 BR 112014026292A2 BR 112014026292 A BR112014026292 A BR 112014026292A BR 112014026292 A BR112014026292 A BR 112014026292A BR 112014026292 A2 BR112014026292 A2 BR 112014026292A2
Authority
BR
Brazil
Prior art keywords
orally disintegrable
disintegrable tablet
producing
tablet
orally
Prior art date
Application number
BR112014026292A
Other languages
English (en)
Other versions
BR112014026292B1 (pt
Inventor
Sekiguchi Gaku
Hayakawa Ryoichi
Hara Yoshihiro
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of BR112014026292A2 publication Critical patent/BR112014026292A2/pt
Publication of BR112014026292B1 publication Critical patent/BR112014026292B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112014026292-6A 2012-04-24 2013-04-23 Comprimido oralmente desintegrável, e, processo para a produção de um comprimido oralmente desintegrável BR112014026292B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012-098770 2012-04-24
JP2012098770 2012-04-24
PCT/JP2013/061936 WO2013161823A1 (ja) 2012-04-24 2013-04-23 口腔内崩壊錠及びその製造方法

Publications (2)

Publication Number Publication Date
BR112014026292A2 true BR112014026292A2 (pt) 2017-06-27
BR112014026292B1 BR112014026292B1 (pt) 2022-09-27

Family

ID=49483132

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014026292-6A BR112014026292B1 (pt) 2012-04-24 2013-04-23 Comprimido oralmente desintegrável, e, processo para a produção de um comprimido oralmente desintegrável

Country Status (12)

Country Link
US (1) US9827200B2 (pt)
EP (1) EP2842549B1 (pt)
JP (4) JP6066351B2 (pt)
KR (1) KR101943686B1 (pt)
CN (2) CN106913553A (pt)
BR (1) BR112014026292B1 (pt)
CA (1) CA2870868C (pt)
ES (1) ES2694224T3 (pt)
HK (1) HK1206983A1 (pt)
IN (1) IN2014MN02029A (pt)
TW (1) TWI572371B (pt)
WO (1) WO2013161823A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015326392B2 (en) * 2014-10-03 2018-10-04 Novartis Ag Pharmaceutical compositions comprising alpelisib
JP5827428B1 (ja) * 2015-01-15 2015-12-02 日新製薬株式会社 テルミサルタン含有錠剤
JP2016141630A (ja) * 2015-01-30 2016-08-08 富士フイルム株式会社 口腔内崩壊錠
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN108066304B (zh) * 2016-11-16 2022-09-16 深圳万和制药有限公司 具有缓释性能的坦索罗辛口腔崩解片组合物
TWI812602B (zh) * 2016-12-01 2023-08-21 日商第一三共股份有限公司 含二胺衍生物之口腔崩散錠及其製造方法
JP7009288B2 (ja) * 2017-05-18 2022-01-25 エルメッド株式会社 湿製錠剤の製造方法及び湿製錠剤の品質向上方法
JP7023186B2 (ja) * 2017-05-29 2022-02-21 第一三共株式会社 認知症治療薬を含有する口腔内崩壊性錠剤
JP7182356B2 (ja) * 2017-07-05 2022-12-02 日本ケミファ株式会社 口腔内崩壊錠及びその製造方法
JP7198575B2 (ja) * 2017-07-11 2023-01-04 キョーリンリメディオ株式会社 メマンチン塩酸塩含有口腔内崩壊錠
JP7148319B2 (ja) * 2017-08-17 2022-10-05 第一三共株式会社 プラスグレルを含む口腔内崩壊錠
US20210059948A1 (en) * 2017-12-26 2021-03-04 Towa Pharmaceutical Co., Ltd. Cyclic orally disintegrating tablet
JP7138666B2 (ja) * 2018-01-24 2022-09-16 大原薬品工業株式会社 γ－アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法
CN110613691A (zh) * 2018-06-19 2019-12-27 北京万全德众医药生物技术有限公司 一种含有peg-dspe-盐酸美金刚复合物的口崩片
TWI826474B (zh) 2018-06-27 2023-12-21 日商第一三共股份有限公司 包含二胺衍生物之顆粒劑、以及其用途及製造方法
CN109512790A (zh) * 2018-12-28 2019-03-26 金日制药（中国）有限公司 一种口腔崩解片的处方及制备工艺
WO2021095092A1 (ja) * 2019-11-11 2021-05-20 大塚製薬株式会社 口腔内崩壊錠
JPWO2022004871A1 (pt) * 2020-07-03 2022-01-06
BR112023000403A2 (pt) * 2020-07-27 2023-02-07 Daiichi Sankyo Co Ltd Comprimido de desintegração oral, e, método para produzir um comprimido de desintegração oral
WO2022102457A1 (ja) * 2020-11-10 2022-05-19 沢井製薬株式会社 リナグリプチン含有口腔内崩壊錠
CN113181125B (zh) * 2021-04-27 2022-07-19 海南通用三洋药业有限公司 一种西他沙星片剂及其制备方法
CN113332252A (zh) * 2021-06-07 2021-09-03 大桐制药（中国）有限责任公司 一种洛索洛芬钠片的制备方法
CN113244238B (zh) * 2021-06-16 2022-05-20 北京斯利安药业有限公司 含盐酸苯海索和叶酸的口崩片及其制备方法
JP7210794B2 (ja) * 2021-06-16 2023-01-23 日本ジェネリック株式会社 リナグリプチン含有製剤及びリナグリプチン含有口腔内崩壊性錠剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW391880B (en) * 1994-01-31 2000-06-01 Yamanouchi Pharma Co Ltd An oral soluble type compression moulding and its preparation
JP4438121B2 (ja) 1998-04-27 2010-03-24 大正製薬株式会社 口腔内速崩錠及びその製造方法
JP2000273039A (ja) 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP5584509B2 (ja) 2003-02-28 2014-09-03 東和薬品株式会社 口腔内崩壊錠剤
JP4551627B2 (ja) * 2003-02-28 2010-09-29 東和薬品株式会社 口腔内崩壊錠剤の製造方法
CN1805737A (zh) * 2003-06-16 2006-07-19 欧乐根公司 美金刚胺(memantine)口服剂型
JP3841804B2 (ja) 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
JP5215172B2 (ja) 2006-04-13 2013-06-19 東亜薬品株式会社 乾式直打速崩壊性錠剤
WO2008018371A1 (fr) * 2006-08-08 2008-02-14 Kissei Pharmaceutical Co., Ltd. Comprimé à désagrégation orale ayant un goût amer masqué et son procédé de production
ES2393640T3 (es) * 2008-02-13 2012-12-26 Dainippon Sumitomo Pharma Co., Ltd. Comprimidos bucodisgregables
JP2010070466A (ja) 2008-09-16 2010-04-02 Kyoto Pharmaceutical Industries Ltd 口腔内崩壊錠
JP5549443B2 (ja) 2009-07-15 2014-07-16 ライオン株式会社 口腔内崩壊錠及びその製造方法
AU2011237122B2 (en) * 2010-03-31 2014-06-12 Mochida Pharmaceutical Co., Ltd. Easily dosable solid preparation
JP5680898B2 (ja) 2010-08-10 2015-03-04 京都薬品工業株式会社 苦味を抑制した速崩壊錠
EP2810659B1 (en) * 2012-02-03 2017-08-09 Asahi Kasei Kabushiki Kaisha Orally disintegrating tablet containing bitterness-masking granules

Also Published As

Publication number Publication date
EP2842549A1 (en) 2015-03-04
JP6325627B2 (ja) 2018-05-16
WO2013161823A1 (ja) 2013-10-31
JP2017008112A (ja) 2017-01-12
CA2870868C (en) 2018-02-20
US20150110880A1 (en) 2015-04-23
EP2842549B1 (en) 2018-08-08
TW201347792A (zh) 2013-12-01
KR101943686B1 (ko) 2019-01-29
HK1206983A1 (en) 2016-01-22
TWI572371B (zh) 2017-03-01
CN106913553A (zh) 2017-07-04
US9827200B2 (en) 2017-11-28
KR20150003740A (ko) 2015-01-09
IN2014MN02029A (pt) 2015-08-14
CA2870868A1 (en) 2013-10-31
JP2019151670A (ja) 2019-09-12
JP6545839B2 (ja) 2019-07-17
JPWO2013161823A1 (ja) 2015-12-24
CN104244930A (zh) 2014-12-24
ES2694224T3 (es) 2018-12-19
BR112014026292B1 (pt) 2022-09-27
JP7028829B2 (ja) 2022-03-02
EP2842549A4 (en) 2015-09-23
JP2018058910A (ja) 2018-04-12
JP6066351B2 (ja) 2017-01-25

Similar Documents

Publication Publication Date Title
BR112014026292A2 (pt) comprimido oralmente desintegrável, e, processo para a produção de um comprimido oralmente desintegrável
BR112014008603A2 (pt) tablete, e, método para produzir um tablete
FI20135922A (fi) Menetelmä kuitumaisen tuotteen muodostamiseksi
BR112014015994A2 (pt) processo.
FR2988583B1 (fr) Cintreuse a came
BR112014015118A2 (pt) processo para a recuperação intensificada de petróleo
BR112015003020A2 (pt) processo para produzir um estruturante cristalino.
BR112014026796A2 (pt) processo
BR112013030546A2 (pt) processo de extrusão.
BR112015007975A2 (pt) processo para preparar continuamente tetrapolímeros, e tetrapolímero
BR112014029236A2 (pt) processo de hidroprocessamento
BR112015002912A2 (pt) processo para a produção de benzoxazinonas
BR112015021297A2 (pt) um processo para a produção de adenovírus.
BR112013010106A2 (pt) processo para a produção de um módulo termoelétrico, e, módulo termoelétrico
FR3004071B1 (fr) Nouvelle confiserie a la croustillance amelioree
BR112014028570A2 (pt) processo para fabricação de compostos de ciclopentilpirimidina hidroxilada.
BR112014023401A2 (pt) método para produzir batoque de perfuração-laminação
BR112016010223A2 (pt) processo para a preparação de iopamidol.
BR112015002780A2 (pt) processo para produção de um módulo de eixo de cames e correspondente eixo de cames
BR112015004662A2 (pt) processo de preparação de ácido sebácico.
BR112015000987A2 (pt) processo para a preparação de 5-fluoro-1h-pirazóis
BR112014017215A8 (pt) método para a produção de um produto químico
BR112014028372A2 (pt) processo de previsão.
BR112014014577A2 (pt) processo autotérmico
BR112014017005A2 (pt) método para a produção de um produto químico

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/04/2013, OBSERVADAS AS CONDICOES LEGAIS